PAR 2.38% 21.5¢ paradigm biopharmaceuticals limited..

PAR. SP, page-750

  1. 9,857 Posts.
    lightbulb Created with Sketch. 1271
    100% agree and would add the negativity towards PR will see plenty of existing holders sell out anywhere near break even simply due to their lack of trust. Delays are tolerable within limits but credibility is another thing all together.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.